购物车
全部删除
您的购物车当前为空
别名 4,7-二氯-1,3-二氢-3-羟基-3-[2-(4-甲氧基苯基)-2-氧代乙基]-2H-吲哚-2-酮
YK 4-279是一种RNA 解旋酶A 与致癌转录因子EWS-FLI1结合抑制剂,能抑制ESFT 细胞增长,诱导凋亡。


为众多的药物研发团队赋能,
让新药发现更简单!
YK 4-279是一种RNA 解旋酶A 与致癌转录因子EWS-FLI1结合抑制剂,能抑制ESFT 细胞增长,诱导凋亡。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 169 | 现货 | |
| 5 mg | ¥ 381 | 现货 | |
| 10 mg | ¥ 612 | 现货 | |
| 25 mg | ¥ 1,230 | 现货 | |
| 50 mg | ¥ 1,990 | 现货 | |
| 100 mg | ¥ 3,180 | 现货 | |
| 200 mg | ¥ 4,480 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 310 | 现货 |
YK-4-279 相关产品
| 产品描述 | YK 4-279, an inhibitor of RNA Helicase A (RHA), binds to the oncogenic transciption factor EWS-FLI1. |
| 体外活性 | 在融合阳性LNCaP-luc-M肿瘤小鼠模型中,YK-4-279能够抑制肿瘤细胞的增殖和迁移.在体内ESFT异种移植瘤中,YK-4-279(1.5 mg/kg i.p. )能够抑制生长. |
| 体内活性 | 在含有EWS-FLI1的TC32细胞中,YK-4-279通过阻断EWS-FLI1与RHA的相互作用,减少细胞周期蛋白D的水平。在ESFT细胞中,YK-4-279能够抑制细胞生长,诱导细胞凋亡。在融合阳性前列腺癌细胞中,YK-4-279能够抑制ERG 和 ETV1的生物活性,减少细胞的迁移。 |
| 激酶实验 | Cytosolic phosphorylation of Akt: Hela cells are serum starved for 1 hr and treated with IGF (100ng/mL) or SC79 (4 μg/mL) for 30 minutes. Cells are lysed in Lysis buffer containing 250 mM Sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA supplemented with protease inhibitors. Cells are passed through 25 g needle several times and kept on ice for 20 minutes. Total cell lysate is taken at this point. Cell lysates are centrifuged at 100,000 g for 30 minutes. Supernatant is collected as the cytosolic fraction. Pellet is washed with lysis buffer and represents the membrane fraction. Total cell lysate, cytosolic and membrane fractions are resolved by SDS-PAGE and analyzed for phospho-Akt (S473), Total Akt, Tubulin (cytosolic marker) and Orai1 (membrane marker) by western blotting. |
| 别名 | 4,7-二氯-1,3-二氢-3-羟基-3-[2-(4-甲氧基苯基)-2-氧代乙基]-2H-吲哚-2-酮 |
| 分子量 | 366.2 |
| 分子式 | C17H13Cl2NO4 |
| CAS No. | 1037184-44-3 |
| Smiles | COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl |
| 密度 | 1.456 g/cm3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 48 mg/mL (131.08 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 68 mg/mL (185.69 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.46 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容